Next Article in Journal
Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I
Next Article in Special Issue
Lessons Learned from Pompe Disease Newborn Screening and Follow-up
Previous Article in Journal
History of Newborn Screening for Cystic Fibrosis—The Early Years
Previous Article in Special Issue
Development of Newborn Screening for Pompe Disease
 
 
Article

Article Versions Notes

Int. J. Neonatal Screen. 2020, 6(1), 9; https://doi.org/10.3390/ijns6010009
Action Date Notes Link
article xml file uploaded 7 February 2020 11:27 CET Original file -
article pdf uploaded. 7 February 2020 11:27 CET Version of Record https://www.mdpi.com/2409-515X/6/1/9/pdf-vor
article xml file uploaded 22 March 2020 11:43 CET Update -
article xml uploaded. 22 March 2020 11:43 CET Update https://www.mdpi.com/2409-515X/6/1/9/xml
article pdf uploaded. 22 March 2020 11:43 CET Updated version of record https://www.mdpi.com/2409-515X/6/1/9/pdf
article html file updated 22 March 2020 11:44 CET Original file -
article html file updated 20 July 2022 19:31 CEST Update https://www.mdpi.com/2409-515X/6/1/9/html
Back to TopTop